News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
742,439 Results
Type
Article (45223)
Company Profile (274)
Press Release (696928)
Multimedia
Podcasts (85)
Webinars (22)
Section
Business (207926)
Career Advice (2074)
Deals (36051)
Drug Delivery (121)
Drug Development (81667)
Employer Resources (173)
FDA (17037)
Job Trends (15335)
News (352210)
Policy (33901)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2638)
Accelerated approval (42)
Adcomms (25)
Allergies (161)
Alliances (50367)
ALS (194)
Alzheimer's disease (1757)
Antibody-drug conjugate (ADC) (366)
Approvals (17358)
Artificial intelligence (600)
Autoimmune disease (223)
Automation (51)
Bankruptcy (366)
Best Places to Work (11735)
BIOSECURE Act (20)
Biosimilars (203)
Biotechnology (179)
Bladder cancer (177)
Brain cancer (64)
Breast cancer (688)
Cancer (5317)
Cardiovascular disease (448)
Career advice (1760)
Career pathing (40)
CAR-T (299)
CDC (54)
Celiac Disease (2)
Cell therapy (798)
Cervical cancer (41)
Clinical research (70383)
Collaboration (1901)
Company closure (4)
Compensation (1272)
Complete response letters (70)
COVID-19 (2735)
CRISPR (98)
C-suite (983)
Cystic fibrosis (148)
Data (7051)
Decentralized trials (3)
Denatured (26)
Depression (153)
Dermatology (57)
Diabetes (555)
Diagnostics (6911)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (295)
Drug pricing (194)
Drug shortages (29)
Duchenne muscular dystrophy (265)
Earnings (92106)
Editorial (60)
Employer branding (21)
Employer resources (152)
Events (120230)
Executive appointments (1040)
FDA (20498)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1628)
Gene editing (210)
Generative AI (51)
Gene therapy (652)
GLP-1 (1019)
Government (4775)
Grass and pollen (6)
Guidances (398)
Healthcare (19170)
HIV (74)
Huntington's disease (52)
IgA nephropathy (91)
Immunology and inflammation (273)
Immuno-oncology (81)
Indications (158)
Infectious disease (3048)
Inflammatory bowel disease (201)
Inflation Reduction Act (14)
Influenza (129)
Intellectual property (273)
Interviews (321)
IPO (16811)
IRA (50)
Job creations (3919)
Job search strategy (1469)
JPM (58)
Kidney cancer (18)
Labor market (92)
Layoffs (558)
Leadership (34)
Legal (8243)
Liver cancer (98)
Longevity (28)
Lung cancer (712)
Lymphoma (406)
Machine learning (53)
Management (59)
Manufacturing (922)
MASH (177)
Medical device (14799)
Medtech (14880)
Mergers & acquisitions (20402)
Metabolic disorders (1415)
mRNA (173)
Multiple sclerosis (173)
NASH (17)
Neurodegenerative disease (382)
Neuropsychiatric disorders (97)
Neuroscience (3153)
Neurotech (1)
NextGen: Class of 2026 (6667)
Non-profit (4552)
Now hiring (73)
Obesity (663)
Opinion (278)
Ovarian cancer (185)
Pain (227)
Pancreatic cancer (256)
Parkinson's disease (339)
Partnered (33)
Patents (554)
Patient recruitment (593)
Peanut (60)
People (60172)
Pharmaceutical (60)
Pharmacy benefit managers (32)
Phase 1 (21937)
Phase 2 (30989)
Phase 3 (23074)
Pipeline (7131)
Policy (302)
Postmarket research (2570)
Preclinical (9304)
Press Release (65)
Prostate cancer (277)
Psychedelics (49)
Radiopharmaceuticals (303)
Rare diseases (989)
Real estate (6137)
Recruiting (70)
Regulatory (25793)
Reports (54)
Research institute (2442)
Resumes & cover letters (357)
Rett syndrome (32)
RNA editing (17)
RSV (85)
Schizophrenia (163)
Series A (268)
Series B (203)
Service/supplier (12)
Sickle cell disease (106)
Special edition (22)
Spinal muscular atrophy (164)
Sponsored (47)
Startups (3778)
State (2)
Stomach cancer (18)
Supply chain (118)
Tariffs (85)
The Weekly (57)
Vaccines (1059)
Venture capital (100)
Weight loss (421)
Women's health (110)
Worklife (19)
Date
Today (43)
Last 7 days (639)
Last 30 days (2682)
Last 365 days (30151)
2026 (8040)
2025 (30405)
2024 (35488)
2023 (40434)
2022 (51545)
2021 (56161)
2020 (54653)
2019 (47287)
2018 (35644)
2017 (32973)
2016 (32686)
2015 (38700)
2014 (32430)
2013 (27580)
2012 (29811)
2011 (30434)
2010 (28445)
Location
Africa (775)
Alabama (91)
Alaska (7)
Arizona (335)
Arkansas (13)
Asia (40978)
Australia (6646)
California (12316)
Canada (3515)
China (1233)
Colorado (529)
Connecticut (530)
Delaware (369)
Europe (87995)
Florida (1848)
Georgia (397)
Hawaii (3)
Idaho (62)
Illinois (969)
India (80)
Indiana (562)
Iowa (22)
Japan (489)
Kansas (129)
Kentucky (44)
Louisiana (39)
Maine (73)
Maryland (1503)
Massachusetts (8804)
Michigan (349)
Minnesota (690)
Mississippi (7)
Missouri (139)
Montana (33)
Nebraska (29)
Nevada (139)
New Hampshire (85)
New Jersey (3273)
New Mexico (29)
New York (3250)
North Carolina (1598)
North Dakota (8)
Northern California (6075)
Ohio (368)
Oklahoma (23)
Oregon (41)
Pennsylvania (2486)
Puerto Rico (26)
Rhode Island (50)
South America (1152)
South Carolina (76)
South Dakota (1)
Southern California (4850)
Tennessee (200)
Texas (1944)
United States (43699)
Utah (370)
Vermont (1)
Virginia (292)
Washington D.C. (81)
Washington State (987)
West Virginia (4)
Wisconsin (121)
Wyoming (2)
742,439 Results for "cellaegis devices inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Breath Diagnostics, Inc. Receives FDA Breakthrough Device Designation for OneBreath™ Platform to Aid Pre-Operative Pneumonia Risk Assessment
February 19, 2026
·
6 min read
Press Releases
Applied Medical Technology, Inc. Announces U.S. Launch of Explant Express® Breast Implant Suction Retrieval Device for Ruptured Implant Removal
February 26, 2026
·
2 min read
Press Releases
Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™
February 10, 2026
·
4 min read
Press Releases
InGeneron, Inc. Announces EU Quality Management System Certificate Under MDR Regulation (EU) 2017/745 for Medical Devices
February 5, 2026
·
2 min read
Press Releases
FDA Clearance Sets Stage for U.S. Commercialization of eyonis® LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc.
February 18, 2026
·
8 min read
Press Releases
Otsuka Medical Devices/Otsuka Pharmaceutical: Paradise Ultrasound Renal Denervation System for the Treatment of Resistant Hypertension, Now Covered by Insurance and Commercially Available in Japan
March 2, 2026
·
3 min read
Press Releases
Vocxi Health and Forj Medical Partner to Miniaturize Breath-Based Cancer Detection Device Platform
Advanced engineering collaboration accelerates development of MyBreathPrint™, a revolutionary Class II medical device platform that detects lung cancer and other diseases from a single minute of breathing
February 26, 2026
·
1 min read
Press Releases
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio
April 2, 2026
·
6 min read
In partnership with PII
Bridging Formulation and Device: Integrated Supply Chain Strategies for U.S. Pharma Manufacturing
The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development with drug delivery device design—and leveraging a single‐vendor ecosystem—can deliver significant time, cost, and regulatory advantages for US‑focused drug products, according to industry experts.
December 8, 2025
·
5 min read
·
Jennifer C. Smith-Parker
Press Releases
Peri Launches First Wearable Device Designed Specifically for Perimenopause
April 2, 2026
·
2 min read
1 of 74,244
Next
